Next Article in Journal
Impact of Plant Growth Regulators on Callus Induction in Cannabis sativa L.
Next Article in Special Issue
Engineering Human Myocardium: Integrating the Maturation of hiPSC-Derived Cardiac Myocytes Across Genetic, Structural, Physiological and Multicellular Systems
Previous Article in Journal
A Comprehensive Adenoid Cystic Carcinoma-Derived Organoid Platform for Disease Modeling and Drug Screening Captures Interpatient Heterogeneity
Previous Article in Special Issue
Electrophysiological Phenotyping of hiPSC-Derived Atrial Cardiomyocytes Using Automated Patch-Clamp: A Platform for Studying Atrial Inherited Arrhythmias
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Transcriptomic Analysis of Adult Mouse Cardiac Stromal Cells Using Single-Cell qRT-PCR

1
Department of Physiology, Anatomy & Genetics, University of Oxford, Oxford OX1 3PT, UK
2
King Faisal Specialist Hospital & Research Centre, Riyadh 12713, Saudi Arabia
3
National Heart and Lung Institute, Imperial College London, London W12 0NN, UK
*
Author to whom correspondence should be addressed.
Cells 2026, 15(4), 384; https://doi.org/10.3390/cells15040384
Submission received: 7 December 2025 / Revised: 12 February 2026 / Accepted: 14 February 2026 / Published: 23 February 2026
(This article belongs to the Special Issue Advances in Cardiomyocyte and Stem Cell Biology in Heart Disease)

Abstract

Fate-mapping studies have challenged the longstanding view of the adult mammalian heart as a post-mitotic organ, suggesting limited cardiomyocyte renewal. This has spurred efforts to determine whether selected cardiac stromal cells have regenerative potential; however, their contribution to cardiac regeneration has been found to be minimal compared with that of cardiomyocyte proliferation. Despite this, transplantation of some cardiac stromal cell populations has shown therapeutic potential through paracrine signalling. The identity of the paracrine-active stromal cell populations remains unclear due to overlapping characteristics with other cardiac stromal cell populations, such as fibroblasts, mesenchymal cells, and pericytes. This study sought to clarify the transcriptional identity and heterogeneity of adult mouse cardiac stromal cells by developing a cardiac collagenase–trypsin protocol and comparing it to the established method for isolating cardiosphere-derived cells (CDCs). This novel protocol resulted in a higher cell yield and shorter expansion time, and the resulting cells showed superior survival under serum starvation compared to commercially acquired cardiac fibroblasts (CFs). Single-cell qRT-PCR analysis revealed that collagenase–trypsin cells (CTs) and CDCs share similar gene expression profiles, distinct from those of CFs. Notably, CTs exhibited higher expression of Tcf21 and lower expression of Tbx5, suggesting an epicardial-derived fibroblast phenotype, whereas Tbx5 was enriched in CDCs and CFs, reflecting heterogeneity within the cardiac fibroblast compartment. This study offers insights into the complex identity of cardiac stromal cells and concludes that CTs closely resemble CDCs but can be generated more rapidly, making them a robust and efficient source of paracrine-active cardiac stromal cells.

1. Introduction

Evidence from fate-mapping studies of cardiomyocyte renewal in the adult mammalian heart has challenged the dogma that considers the heart a post-mitotic organ [1,2,3]. Therefore, multiple research groups have attempted to characterise endogenous cardiac stromal cell populations that may play a role in the regenerative process. Identifiers of the presumed cardiac progenitor cell (CPC) populations include the SP dye-efflux phenotype [4,5], SCA1 [6], KIT [7,8], ISL1 [9,10], cardiosphere- and colony-forming assays [11,12], and re-activation of the embryonic epicardial programme with WT1 upregulation [13] (reviewed in Alonaizan and Carr, 2022 [14]). More recent findings indicate that the mechanism behind cardiomyocyte renewal is cardiomyocyte proliferation, and that the contribution of the presumed CPC populations is minimal [1,2,3,14,15,16]. Despite their low cardiomyogenic potential after transplantation into the infarcted heart, these stromal cell populations have demonstrated therapeutic benefits in pre-clinical studies, primarily through paracrine signalling [6,12,13,17,18].
The identity of the paracrine-active stromal cell (PASC) populations remains unclear, with numerous studies questioning the distinctions between these cells and various other cardiac stromal cell populations, including mesenchymal cells, fibroblasts, and pericytes [19,20,21,22,23]. This uncertainty stems from the overlap in their morphology and gene expression profiles. For instance, cardiac fibroblasts, like PASCs, express core cardiac transcription factors that contribute to cardiac development and repair [24]. Both cardiac and tail fibroblasts share a molecular signature similar to that of mesenchymal stem cells (MSCs) [25]. Significant efforts have been made to distinguish between these cardiac stromal cell populations. To complicate matters further, single-cell transcriptional profiling of mouse ventricular non-myocytes has revealed subpopulation heterogeneity within the cardiac fibroblast population [26]. Additionally, markers commonly used to identify pericytes are relatively non-specific, although some genes are enriched in pericytes compared to other cell types [26].
We developed a cardiac collagenase–trypsin protocol adapted from studies by Gharaibeh et al. [27] and Okada et al. [28] for isolating slowly adhering cells (SACs) from skeletal muscle. These SACs demonstrated superior differentiation, survival, and therapeutic potential compared to rapidly adhering cells (RACs). Similarly, we showed that collagenase–trypsin cells (CTs) can be induced to differentiate into the cardiomyocyte lineage in vitro [29] using TGFβ1 stimulation [30,31]. We also showed that fatty acid supplementation triggered a metabolic switch via the PPARα pathway, as evidenced by upregulated oxidative metabolism and increased expression of cardiomyocyte markers in CTs [29]. This finding aligns with the metabolic switch from glycolysis to fatty acid oxidation observed during cardiomyocyte maturation in development [32] and in zebrafish heart regeneration [33]. In addition, CTs were found to secrete a range of growth factors, including IGF-1, IGFBP-2/3, M-CSF, and VEGF-A, and their conditioned media increased HUVEC proliferation and reduced apoptosis in HL-1 cardiomyocytes under simulated ischaemia/reperfusion. These effects were further enhanced by hypoxic conditioning of CTs through hypoxic culture and/or miRNA-210 overexpression [34]. In this study, we compare CTs with the more established cardiosphere-derived cells (CDCs) and with commercially acquired primary cardiac fibroblasts (CFs) using single-cell qRT-PCR and cell survival assays. Our aim is to determine whether CTs more closely resemble CDCs or cardiac fibroblasts, to dissect the molecular signatures of cardiac stromal populations obtained using different isolation methods, and to highlight their heterogeneity, which may reflect underlying functional heterogeneity.

2. Materials and Methods

2.1. Mice

Male C57BL/6 mice aged 8–12 weeks (Harlan, Oxon, UK) were kept under a 12 h light–dark cycle and controlled conditions of temperature and humidity, with free access to water and chow. All animal procedures were reviewed and approved by the University of Oxford Animal Welfare and Ethical Review Board and conformed to the Animals (Scientific Procedures) Act 1986, incorporating Directive 2010/63/EU of the European Parliament (PPL #3003322, approved 5 December 2017).

2.2. Isolation and Expansion of Mouse CTs and CDCs

Mice were terminally anaesthetised with isoflurane, and hearts were isolated and washed with Dulbecco’s phosphate-buffered saline (DPBS) containing 50 mg primocin (antimicrobial agent; InvivoGen, Toulouse, France). Mouse atrial appendages were dissected and mechanically minced into 1–2 mm3 pieces. Cells from a single heart were seeded into one well of a 12-well plate for each biological replicate.
For CT isolation, the tissue pieces were then transferred into a digestion mixture (0.1% trypsin and 0.1% collagenase II (Calbiochem, Merck KGaA, Darmstadt, Germany, 286 U/mg) in DPBS) and incubated in a water bath at 37 °C for a total of 40 min. Every 10 min, the digestion mixture was mechanically triturated by pipetting, left on ice for 1 min to settle, and the supernatant was collected. Fresh digestion mixture was added to the tissue pieces for a total of 4 digestions. During the final digestion step, sterile 19 G needles and 1 mL syringes were used to triturate the tissue. After each digestion, the supernatant was neutralised, and the cell suspension was resuspended in fresh complete explant medium (CEM; Iscove’s modified Dulbecco’s medium supplemented with 20% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 2 mM L-glutamine, ThermoFisher, Waltham, MA, USA) [12] and plated in a 12-well plate through a 40 µm cell strainer. The wells were pre-coated with 50 µL per cm2 of fibronectin (2 µg/mL in DPBS; Sigma-Aldrich, St. Louis, MO, USA) and cells were allowed to attach for 3 days without medium changes.
For CDC isolation [12], the tissue pieces were digested in 0.05% trypsin-EDTA (ThermoFisher) for 4 min at 37 °C, then neutralised with CEM. Processed tissue pieces were plated on fibronectin-coated (3 μg/mL in DPBS) 6-well plates containing CEM, and explants were cultured for 25–30 days at 37 °C in 5% CO2, with media changes every 2–3 days. When explant-derived cells (EDCs) reached 70–80% confluency, they were harvested by washing with 0.53 mM Versene (ThermoFisher) before trypsin digestion. EDCs were resuspended in Cardiosphere Growth Medium (CGM), comprising 65% Dulbecco’s modified Eagle medium (DMEM/F12), 35% IMDM, 7% foetal bovine serum (FBS; ThermoFisher), 2% B27 (ThermoFisher), 25 ng/mL cardiotrophin (Peprotech, Waltham, MA, USA), 10 ng/mL epidermal growth factor (EGF; Peprotech EC), 20 ng/mL basic fibroblast growth factor (FGF; Promega, Madison, WI, USA), and 5 units thrombin (Sigma-Aldrich), at a concentration of 2 × 104 cells/mL and seeded as 25 µL droplets on an uncoated lid of a Petri dish. DPBS was added to the Petri dishes to maintain humidity throughout 3 days of culture, allowing spherical multicellular clusters, known as cardiospheres, to form. Cardiospheres were collected by elution and gentle pipetting with DPBS and plated in fibronectin-coated 12-well plates with CEM, allowing spontaneous release of CDCs.

2.3. Cell Culture

Primary CTs and CDCs were cultured in CEM and plated on fibronectin-coated flasks. HL-1 cardiomyocytes [35] were maintained in Claycomb medium (Sigma-Aldrich), supplemented with 100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine (ThermoFisher), 100 µM norepinephrine (Sigma-Aldrich) in 30 mM L-ascorbic acid (Sigma-Aldrich), and 10% FBS and plated on flasks pre-coated with 0.02% (wt/vol) gelatin (Sigma-Aldrich) containing 5 µg/mL fibronectin. C57BL/6 adult mouse atrial primary cardiac fibroblasts, obtained from Cell Biologics (Chicago, IL, USA), were maintained in complete fibroblast medium (Cell Biologics) supplemented with the provided supplement kit: FGF, hydrocortisone, L-glutamine, Antibiotic-Antimycotic Solution, and 10% FBS, and plated on flasks pre-coated with 0.02% (wt/vol) gelatin. As CFs were purchased and not isolated in our laboratory, some information is lacking, e.g., the age of the mice, duration of cell attachment, and composition of the accompanying media (Figure 1A).

2.4. Serum Starvation

For serum starvation experiments, cells were switched to serum-free medium for 72 h. Results are presented as means ± standard deviation. Statistical analysis was performed using GraphPad Prism (version 10.3.0). Data were analysed using a two-way analysis of variance (ANOVA) with Tukey’s post hoc test. Sample sizes are provided in the figure legends. Statistical significance was defined as p < 0.05.

2.5. Single-Cell qRT-PCR

Single cells were sorted directly (FACSAria II) into 96-well plates containing the reaction mixture for pre-amplification using CellsDirect One-Step qRT–PCR Kits (ThermoFisher). Pre-amplification was performed in a Veriti Thermal Cycler (Applied Biosystems, ThermoFisher) for 22 cycles. As negative controls, at least 3–5 non-template samples were included in each run at the pre-amplification stage. Quantitative amplification was performed using Dynamic Array chips (Fluidigm, Eurofins, Ebersberg, Germany) for 48 assays × 48 samples, the BioMark HD system (Fluidigm), and TaqMan probes (ThermoFisher) (Table 1), according to the manufacturer’s instructions. Each sample was normalised to ΔCt using Ubc expression. As described in Noseda et al. 2015 [6], data were plotted as colour-coded heatmaps of inverted ΔCt values (blue indicates low or absent expression; red indicates high expression). Samples were ordered by cell type, and genes were grouped using a hierarchical clustering algorithm based on the underlying co-expression pattern. Differences between samples were investigated using PCA. PCA applies multiple linear transformations (singular value decomposition) to the expression profiles (standardised ΔCt values) of individual samples and identifies a series of PCs that elucidate the most distinguishing features among the samples. The linear projections (PC scores) attempt to maximise variation among the samples, whereas the coefficients of those projections (PC loadings) measure the importance of genes in defining the underlying variability associated with each component. Due to the limited number of biological replicates, nonparametric statistical analyses were applied with consideration of multiple testing. To identify differential gene expression across the four cell populations, the Kruskal–Wallis test was applied to the expression data. The resulting p-values were adjusted for multiple comparisons using Dunn’s correction. Spearman correlation coefficients were calculated for all gene pairs using –ΔCt values from the complete single-cell qRT-PCR dataset, including HL-1 cardiomyocytes and stromal populations. The correlations were visualised as a dot plot, in which dot size and colour represent the strength and direction of co-expression, respectively.

3. Results

3.1. The CT Protocol Produces Higher Cell Yield than CDCs but a Similar Survival Potential

CTs and CDCs were isolated from adult mouse atrial tissue and expanded for further analysis. The average time to reach 90% confluence at passage 0 and passage 1 was considerably shorter for CTs, taking approximately 10 and 20 days, respectively. In contrast, CDCs required around 40 days to reach passage 0 and 60 days to reach passage 1 (Figure 1B) due to the additional steps involved in explant culture and cardiosphere formation (Figure 1A).
After expansion to passage 3, we assessed the survival potential of CTs compared to CDCs and commercially acquired CFs to determine their robustness for transplantation. Serum in cell culture media provides amino acids and fatty acids, and its withdrawal is therefore considered a form of nutrient restriction and an effective means of inducing cell apoptosis [34,36]. Therefore, serum starvation was used to challenge the cells in culture for 3 and 10 days. CTs, CDCs, and CFs continued to grow following serum starvation, with no significant difference in cell numbers detected at day 3. At day 10, CT cell numbers were significantly higher than those of CFs but not CDCs, suggesting that CTs have a superior survival potential compared to CFs (Figure 1C).

3.2. Single-Cell Profiling of Cardiac Stromal Cells

CTs, CDCs, and CFs isolated from adult mouse atrial tissue were expanded to passage 3 for single-cell qRT-PCR analysis and compared with the HL-1 cardiomyocyte line, which was used as a control (Figure 2). The genes selected for this experiment (detailed in Appendix A, Table A1) included those encoding core cardiac transcription factors, stem cell-related markers, fibroblast markers, cardiomyocyte markers, and other genes that were differentially expressed in the SCA1 subpopulations according to the study by Noseda et al. [6]. Moreover, we attempted to detect distinct cardiac subpopulations, including pericytes, endothelial cells, and macrophages, within the cardiac stromal cell populations. The heatmap (Figure 2A) shows that the HL-1 cardiomyocytes were distinct from the cardiac stromal cells; expression of each gene across the different populations is shown in Figure 2B. The cardiac stromal populations expressed the fibroblast-associated genes Cd44, Ddr2, Pdgfrb, Acta2 (encodes αSMA), and Vim, although CFs showed less consistent expression of Pdgfrb and Acta2. Interestingly, Ddr2, Acta2, and Vim were also expressed by HL-1 cardiomyocytes. Additionally, on rare occasions, CFs (n = 2/29) and CTs (n = 3/55) co-expressing Wt1 and Tcf21 were detected, perhaps suggesting an epicardial-derived fibroblast identity. Ly6a (encoding SCA1) and Pdgfra were expressed in all three populations. The three cardiac stromal populations expressed little or no Prg4 and Wif1 but displayed expression of Medag and Col1a1. Ms4a4d expression was detected only in CTs and in some CFs. Regarding pericyte-associated markers, Kcnj8 showed little or no expression in all populations, Colec11 showed sporadic expression, whereas Ng2 showed high expression in all three cardiac stromal populations.
In CTs and CDCs, the most prevalent cardiac transcription factors were Gata4, Tbx20, Hand2, and Mef2a, with little or no expression of Hand1, Isl1, or Nkx2-5. In contrast, CFs showed less uniform expression of Gata4, Tbx20, and Hand2. Unlike CDCs, both CTs and CFs expressed Mef2c heterogeneously. The expression of Tbx5 in CFs followed a similar pattern to that in CDCs but was more sporadic in CTs. Interestingly, only CFs expressed Isl1, which has a very limited expression profile in the adult heart [9,37]. The three cardiac stromal populations showed little or no expression of markers of cardiomyocytes (Nppa, Myh6, and Myl2), haematopoietic cells (Ptprc), or endothelial cells (Cdh5 and Vwf), except for Kdr expression, which was detected in CTs, CFs, and HL-1 cardiomyocytes. Expression of stem cell-related markers (Pou5f1, Nanog, Klf4, and Tert) was observed in the three cardiac stromal populations. Pou5f1, Nanog, and Klf4, but not Tert, were also expressed in HL-1 cardiomyocytes. As expected, HL-1 cardiomyocytes had a distinctly different expression profile and displayed expression of most core cardiac transcription factors (Gata4, Hand2, Mef2a/c, Nkx2-5, and Tbx5/20) and cardiomyocyte markers (Nppa, Myh6, and Myl2).
Expression of Schwann cell-related markers (Plp1 and Kcna1) was detected sporadically in all populations, except HL-1 cardiomyocytes, in which only Plp1, but not Kcna1, was expressed. We also assessed the expression of the macrophage-associated genes Mrc1, Csf1r, and Cx3cr1. Cx3cr1 showed no expression in any population, and Mrc1 was expressed only in CTs. In contrast, Csf1r was expressed in all three stromal populations but showed a more uniform pattern in CTs.

3.3. A Comparison of the Molecular Profiles of CTs, CDCs, and CFs

By principal component analysis (PCA), cardiac stromal cells and HL-1 cardiomyocytes were resolved as discrete groups, consistent with their distinct phenotypes. Gene loadings contributing to each dimension (Dim) suggest that a small subset of genes explains the cross-group variability captured by Dim.1 and Dim.2. The separation of HL-1 cardiomyocytes was attributable to Wif1, Nkx2-5, Mef2c, Nppa, Myl2, and Myh6 (Figure 3A). Some separation of CFs from CTs was also revealed, with the CDCs clustering between the other two populations. This is more clearly seen in the PCA of the stromal populations alone (Figure 3B). The separation of CTs was attributable to Tcf21, as evident in Figure 3B, while the separation of CDCs and CFs was mainly attributable to Tbx5. This Tcf21 versus Tbx5 polarity may reflect functional or origin heterogeneity within cardiac fibroblasts. CFs appeared more dispersed, suggesting higher heterogeneity, compared with CTs and CDCs, which again is more apparent in the PCA of stromal populations only.
Statistical analysis comparing the three cardiac stromal populations revealed that CTs were more similar to CDCs than CFs, with CTs showing significantly higher expression of Vim (p < 0.05), Kdr (p < 0.05), Mrc1 (p < 0.001), Tcf21 (p < 0.0001), Ms4a4d (p < 0.0001), Tbx20 (p < 0.0001), Csf1r (p < 0.0001), Mef2c (p < 0.0001), and Medag (p < 0.05) but lower expression of Tbx5 (p < 0.0001) and Acta2 (p < 0.01) compared to CDCs. In comparison to CFs, CTs showed significantly higher expression of Col1a1 (p < 0.0001), Pdgfrb (p < 0.0001), Hand2 (p < 0.0001), Pou5f1 (p < 0.05), Mrc1 (p < 0.001), Tcf21 (p < 0.0001), Tbx20 (p < 0.0001), Ng2 (p < 0.01), Mef2c (p < 0.05), Medag (p < 0.001), and Gata4 (p < 0.0001) but lower expression of Isl1 (p < 0.0001) and Tbx5 (p < 0.01) (Figure 4A).
Finally, we performed a co-expression correlation analysis using the complete single-cell qRT-PCR dataset to support the inferred biological functions of the stromal and cardiomyocyte populations and to identify co-expression relationships among the genes included in the study (Figure 4B). Correlation plot analysis showed a polarisation between the expression of some fibroblast-associated markers and core cardiac transcription factors, and a positive correlation between the expression of core cardiac transcription factors and cardiomyocyte markers. Tcf21 expression showed a positive correlation with the expression of Tbx20, Ms4a4d, and macrophage-associated genes Csf1r and Mrc1, reflecting their high co-expression in CTs. In addition, expression of the pericyte-associated gene Kcnj8 showed a positive correlation with the expression of Isl1 due to their co-expression pattern in a small number of CFs. Collectively, these data confirm the co-expression of core cardiac transcription factors, associated predominantly with CTs and CDCs, as distinct from the gene profile characterising CFs. Additionally, the enrichment of Tcf21 expression in CTs further delineates CTs from CFs.

4. Discussion

4.1. CTs Exhibit Shorter Expansion Time and Superior Survival Potential Following Serum Starvation

Low survival and retention of transplanted cells following ischaemic events are mainly due to the harsh conditions within the infarct region that include hypoxia, inflammation, and nutrient restriction. Serum in cell culture media provides amino acids and fatty acids, and its withdrawal is therefore considered a form of nutrient restriction; serum starvation is an effective means of inducing cell apoptosis [36]. Here, we found that all three cardiac stromal populations continued to grow following serum starvation, with no significant difference in cell numbers detected at day 3. However, CF cell numbers at day 10 were similar to initially seeded numbers, suggesting substantial cell death. At day 10, CT cell numbers were significantly higher than those of CFs but not CDCs, suggesting that CTs have superior survival potential compared with CFs. This is consistent with the single-cell qRT-PCR results showing that CTs and CDCs share a more similar gene expression profile compared with CFs. Tolerance to serum starvation has also been observed in MSCs under both normoxic and hypoxic culture conditions [38,39].
Reduced robustness was observed during routine culture of CFs compared with CTs and CDCs, as shown by increased time to reach confluency and higher numbers of floating dead cells in culture. CFs displayed reduced recovery following single-cell sorting for the single-cell qRT-PCR experiment compared with CTs and CDCs. It is difficult to pinpoint the cause of this fragility due to differences in gene expression, cell culture media, and coating substrate. Differential effects of various culture coating substrate types on cell proliferation have been shown [40]. However, standardising the culture conditions of all cell types would have been counterproductive, as our aim was to compare the populations as they would be cultured in other laboratories based on their recommended and published culture conditions. Ideally, the survival potential of these different stromal populations should be compared following transplantation into infarcted hearts or in in vitro conditions that more closely mimic the in vivo environment following MI. Overall, our data suggest that CTs and CDCs were more robust than CFs, both in long-term cell expansion and survival under serum starvation. The survival potential of cardiac stromal populations may differ in response to stress in vitro, which can be an indication of their in vivo behaviour following transplantation. Additionally, the reduced expansion time needed to generate CTs compared to CDCs indicates that a CDC-like population for therapeutic use could be achieved more efficiently.

4.2. CTs and CDCs Show a Fibroblast Phenotype with No Evidence of Endothelial Cells or Pericytes

A study by Skelly et al. (2018) examined the single-cell transcriptional profile of adult mouse ventricular nonmyocytes to identify distinct cell populations [26]. Subpopulation heterogeneity within the cardiac fibroblast population was described, where most fibroblasts (“fibroblasts 1”) were characterised by high expression of Medag, Ms4a4d, Pdgfra, and Tcf21, while a smaller, distinct cluster (“fibroblasts 2”) expressed higher levels of Tbx20, Wif1, and Prg4. Although we found that Tbx20 was highly expressed in both CTs and CDCs, Wif1 and Prg4 showed little to no expression in any stromal population. Moreover, Medag and Pdgfra expression was detected in all three populations, whereas Ms4a4d and Tcf21 were only found in CTs and CFs. However, CFs showed less consistent expression of Ms4a4d compared to CTs. This suggests that none of the three stromal populations fit the expression pattern of “fibroblasts 2” and that CTs were the best match to the expression pattern of “fibroblasts 1”. However, an important consideration is that the study by Skelly et al. examined ventricular rather than atrial nonmyocytes and used freshly isolated cells rather than passaged cells, which may undergo phenotypic drift in vitro. Additionally, a limitation of this study is the use of commercially sourced CFs as a reference population. While providing a standardised comparator, variables such as donor age, isolation methods, passage history, and batch variability are not fully defined and may influence gene expression profiles. These factors should therefore be considered when interpreting comparative results.
Additional mesenchymal- and fibroblast-associated genes were assessed, including Vim, Ddr2, Acta2, Cd44, and Col1a1. αSMA, encoded by Acta2, is a protein commonly used to identify smooth muscle cells, pericytes, and myofibroblasts, which acquire a contractile phenotype similar to that of smooth muscle cells upon differentiation [41]. Vim was the only gene expressed in all the screened cells of all populations. Vimentin is an intermediate filament protein that has been widely used as a reliable marker of mesenchymal cells, highly migratory cells derived by EMT, and it has a protective role against nuclear rupture and DNA damage during migration [42]. None of these markers showed specificity to a particular population. Vim, Ddr2, and Acta2 were also expressed in HL-1 cardiomyocytes, an adult immortalised atrial cell line that resembles a mitotic embryonic cardiomyocyte rather than a mature adult cell [35], as reflected by its immature energy metabolism [43]. The expression of mesenchymal- and fibroblast-associated genes in HL-1 cardiomyocytes may reflect the lack of specificity of these markers in in vitro cultures, the immature phenotype of HL-1 cardiomyocytes, and/or their dedifferentiation in culture. Genomic instability is a common setback associated with the use of cell lines in research [44]. Accordingly, HL-1 cells are used here as an in vitro reference for cardiomyocyte-associated gene expression rather than as a model of mature primary cardiomyocytes. Nonetheless, the data suggest a fibroblast-like phenotype for all stromal populations. A combination of Pdgfra, Col1a1, and Medag, expressed in stromal cells but not in HL-1 cells, might provide a more reliable set of markers for identifying in vitro fibroblast cultures.
Commonly used markers to identify pericytes (e.g., Pdgfrb and Ng2) are relatively non-specific. However, Kcnj8 and Colec11 have been identified as genes that show higher expression in pericytes relative to other cell types [26]. We found little or no expression of Kcnj8 in any population. Colec11 showed sporadic expression, whereas Ng2 and Pdgfrb showed high expression in all three cardiac stromal populations. Therefore, there is no conclusive evidence that these stromal populations have a pericyte phenotype. Our data also suggest that Kcnj8 and Colec11 may be more specific markers of pericytes than commonly used markers. Moreover, Kcnj8 expression was positively correlated with Isl1, attributable to co-expression in a small number of CFs. ISL1-mediated differentiation of coronary pericytes into coronary artery smooth muscle cells has been described in the embryonic heart [45]. Although Isl1 is detected in the developing heart and multipotent ISL1+ progenitors play an important role in giving rise to cardiac lineages during development [46], ISL1+ cells are very rare in adult human and murine hearts [10,47].
The three cardiac stromal populations showed very little or no expression of markers of cardiomyocytes (Nppa, Myh6, and Myl2), haematopoietic cells (Ptprc), or endothelial cells (Cdh5 and Vwf). Expression of Nppa and Myh6 was detected in a few CDCs (2 Nppa+ cells, n = 41) and CTs (4 Myh6+ cells, n = 55). Given that these cells were at passage 3, it is highly unlikely that the Nppa- or Myh6-expressing cells are surviving cardiomyocytes from the isolation protocol. This expression may result from spontaneous differentiation in culture or may reflect progenitor status. In addition, Kdr expression, a marker of endothelial cells, was detected in the CTs, CFs and HL-1 cardiomyocytes. During development, KDR+ progenitors derived from the MESP1+ mesodermal lineage possess cardiovascular tri-lineage potential [48,49]. Lineage tracing has shown that precursors expressing Gata5 and Wt1 give rise to the adult SCA1+ SP+ population (PDGFRα+/CD31), whereas the adult SCA1+ SP population (PDGFRα/CD31+) is mainly derived from precursors expressing Kdr [6]. However, CTs lack the expression of other endothelial markers observed in the SCA1+ SP population. Kdr expression has also been reported in coronary adventitial progenitors with cardiogenic potential [50] and in endothelial progenitors [51]. Therefore, Kdr expression may reflect some progenitor status rather than the presence of endothelial cells. CDCs have been examined at the single-cell transcriptomics level [52] and characterised as mesenchymal/stromal/fibroblast-like, with a small subset of endothelial-like cells. Notably, transplantation of SCA1+ CDCs, but not SCA1 CDCs, enhanced cardiac function after MI, highlighting previously unappreciated functional differences between CDC subpopulations.
A few cells co-expressing Wt1 and Tcf21 were detected in both the CF and CT populations. In the developing heart, epicardium cells are identified through the expression of Wt1, Tbx18, Tcf21, and Raldh2 [53]. The majority of TCF21+ epicardium-derived cells (EPDCs) are committed to the cardiac fibroblast lineage, and Tcf21 expression persists in cardiac fibroblasts of the adult heart [54,55,56]. Although WT1 is downregulated following gestation [57,58], its expression is still detected in the epicardium and a subset of coronary endothelial cells in the healthy adult heart [55,59]. Enrichment of the epicardial markers Wt1 and Tcf21 has been shown in adult cardiac fibroblasts [24]. More recent studies have shown that Wt1 is expressed in more cell types than previously appreciated, including a Wt1b+ macrophage subpopulation essential for zebrafish heart and fin regeneration [60]. In our data, Wt1 expression did not correlate with Mrc1 or Kdr, but all cells expressing Wt1 were also positive for Tcf21, suggesting a fibroblast phenotype.
Expression of stem cell-related markers (Pou5f1, Nanog, Klf4, and Tert) was observed in all three cardiac stromal populations. In addition, Pou5f1, Nanog, and Klf4, but not Tert, were also expressed in HL-1 cardiomyocytes. The expression of these stem cell-associated genes (Pou5f1, Klf4, Nanog) has been observed in mouse cardiac stromal populations and rat CDCs [61]. A sporadic expression of these markers has also been noted in primary neonatal cardiomyocytes [6]. Other studies have also reported the expression of Pou5f1 [62], Klf4 [63], and Nanog [64,65] in adult differentiated cells. Furthermore, Tert is activated in human and mouse primary fibroblasts to protect against malignant transformation [66]. As stem cell-associated genes are implicated in tumorigenesis and proliferation [67,68], their expression in HL-1 cells and cardiac stromal populations is not unexpected.

4.3. Tcf21 Versus Tbx5 Polarity May Represent Functional Heterogeneity in Fibroblast Populations

Noseda et al. [6] revealed an enrichment of Tcf21 and Pdgfra; the core cardiac genes Gata4, Mef2a/c, Tbx5/20, and Hand2; and a lack of Cdh5 and Kdr in the SCA1+ SP+ population compared with total SCA1+ and SCA1+ SP populations. In our study, Cdh5 expression was absent in all cardiac stromal populations. Both CTs and CDCs showed high expression of the core cardiac transcription factors [69] Gata4, Tbx20, Hand2, and Mef2a, with CTs expressing Mef2c and CDCs expressing Tbx5. Interestingly, among these transcription factors, Tbx5 showed the lowest expression in the SCA1+ SP+ population. Moreover, these results are consistent with observations by Furtado et al., showing enrichment of core cardiac genes in cardiac fibroblasts [24]. In contrast, CFs showed less uniform expression of Gata4, Tbx20, and Hand2. PCA revealed an interesting polarisation between Tcf21 and Tbx5, which was also reflected in the correlation plot, showing a strong negative correlation between the two genes. Indeed, the clustering separation of CTs and CFs can be attributed to the expression of these two genes. Although the significance of this polarisation remains unclear, it is an interesting observation that warrants further investigation, as it may indicate functional heterogeneity among fibroblast populations.
In addition to Tcf21 enrichment in CTs relative to other stromal populations, the macrophage-associated gene Mrc1 was detected in a subset of CTs. This was reflected in the positive correlation between Mrc1 and Tcf21 and the negative correlation between Mrc1 and Tbx5. Mrc1 is reported to be more highly expressed in macrophages relative to other cardiac cell types [26]. Csf1r, enriched in M2-polarised macrophages [70], was expressed in all stromal populations, albeit at significantly higher levels in CTs. Csf1r expression has also been used as an indicator of embryonic myeloid lineage commitment [71]. However, cells expressing Mrc1 or Csf1r also co-expressed fibroblast markers and did not form distinct clusters. In a study using scRNA-seq data to explore the transcriptional profile of CSF1R+ monocytes, a small population of fibroblast-like cells expressing Pdgfrα, Pdgfrb, and Tcf21 was identified [72]. However, in a follow-up study, the authors analysed published data and concluded that fibroblasts do not express detectable levels of Csf1r or Cx3cr1 [73]. Hybrid mesenchymal phenotypes have been described previously, where fibroblast-associated genes are expressed in minor subpopulations of macrophages or endothelial cells [26]. However, because the hematopoietic marker Ptprc is absent in CTs, it is more likely that macrophage-associated genes were upregulated in a subset of fibroblasts rather than the reverse. This phenomenon has also been observed in in vitro fibroblast cultures [74] and may result from in vitro expansion.

5. Conclusions

Our results suggest that (1) CTs are similar to CDCs and differ from CFs in their expression profiles, enrichment of core cardiac factors, and robustness; (2) CTs, CDCs, and CFs resemble “fibroblasts 1”, the predominant fibroblast subtype in the adult murine heart; (3) CDCs cluster between CTs and CFs, which separate based on their expression of Tcf21 and Tbx5, respectively; (4) CTs are enriched for the macrophage-associated genes Mrc1 and Csf1r, likely reflecting a fibroblast phenotype in a subset of CTs; and (5) PCA reveals a transcriptional gradient, suggesting heterogeneity within fibroblast subtypes that may correspond to functional differences. Overall, our findings highlight the heterogeneity of the cardiac stromal compartment and how isolation protocols may enrich for specific cell subpopulations.

Author Contributions

Conceptualisation, R.A., N.S., M.N. and C.C.; formal analysis, R.A. and P.C.-G.; investigation, R.A., P.C.-G. and S.S.; resources, M.N. and C.C.; data curation, R.A. and P.C.-G.; writing—original draft preparation, R.A.; writing—review and editing, R.A., N.S. and C.C.; supervision, N.S. and C.C.; funding acquisition, R.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the King Faisal Specialist Hospital & Research Centre (PhD scholarship to R.A.).

Institutional Review Board Statement

The animal study protocol was approved by the University of Oxford Animal Welfare and Ethical Review Board and conforms to the Animals (Scientific Procedures) Act 1986, incorporating Directive 2010/63/EU of the European Parliament (PPL #3003322 approved 5 December 2017).

Data Availability Statement

Inquiries can be directed to the corresponding author.

Acknowledgments

We would like to thank Andrea Massaia for the R script used in the single-cell qRT-PCR analysis.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CDCsCardiosphere-derived cells
CPCsCardiac progenitor cells
CEMComplete explant medium
CFsCardiac fibroblasts
CTsCollagenase–trypsin cells
EDCsExplant-derived cells
EPDCsEpicardium-derived cells
MSCsMesenchymal stem cells
PASCsParacrine-active stromal cells
RACsRapidly adhering cells
SACsSlowly adhering cells

Appendix A

Table A1. Description of the markers used in the single-cell qRT-PCR characterisation.
Table A1. Description of the markers used in the single-cell qRT-PCR characterisation.
GeneFull Name of Encoded Protein TypeRelevant Expression PatternRelevant Function References
Cd44Cluster of differentiation 44Transmembrane glycoproteinFibroblasts, macrophages, endothelial cellsCellular adhesion; angiogenesis; cytokine release; regulates inflammation and fibrosis[75,76,77,78]
Cdh5Cadherin 5 or VE-cadherinMember of the cadherin family of calcium-dependent glycoproteinsEndothelial cellsCalcium-dependent cell adhesion; cell proliferation and migration[75,79]
Col1a1Collagen, type I, alpha 1Member of group I collagenFibroblasts, smooth muscle cellsCollagen type I synthesis[75,80]
Colec11Collectin subfamily member 11Member of the collectin family of C-type lectinsPericytes, endothelial cellsCollectins initiate the lectin complement pathway, which is integral to the innate immune response; embryogenesis[26,75,81,82]
Csf1rColony-stimulating factor 1 receptorReceptor tyrosine kinaseMacrophages (used as an M2 marker)Growth and differentiation of macrophages; maintenance of the intestinal stem cell niche[70,83]
Cx3cr1CX3C chemokine receptor 1Member of the 7-transmembrane G protein-coupled receptor familyMacrophagesMacrophage survival and function [75,84,85]
Ddr2Discoidin domain receptor tyrosine kinase 2 or CD167bReceptor tyrosine kinaseFibroblasts, smooth muscle cells, pericytesActivated by collagen binding; cell proliferation; adhesion and migration; ECM degradation[75,86,87]
Gata4GATA binding factor 4Transcription factor of the zinc-finger GATA familyCardiomyocytes, cardiac fibroblastsCardiogenesis[24,25,88,89,90]
Hand1Heart- and neural crest derivatives expressed protein 1Transcription factor of the basic helix-loop-helix familyFHF; reported to be undetectable in adult mouse hearts Cardiogenesis; epicardial development and coronary vessel formation[91,92,93,94]
Hand2Heart- and neural crest derivatives expressed protein 2Transcription factor of the basic helix-loop-helix familySHF, cardiomyocytes, endothelial cells, fibroblasts Cardiogenesis; epicardial development and coronary vessel formation[6,25,91,92,94]
Isl1Insulin gene enhancer protein 1Transcription factor of the LIM/homeodomain family CPCs, cardiac neural crest, endothelial cellsCardiogenesis[9,10,46,47,95]
Kcna1Potassium voltage-gated channel subfamily A member 1Member of the 6-TM familySchwann cellsRegulates membrane excitability[26,75,96]
Kcnj8Potassium inwardly rectifying channel, subfamily J, member 8The inward-rectifier potassium channel family (also known as 2-TM channels)PericytesRegulates vascular tone and cardiac adaptive response to systemic metabolic stress[26,75,97,98,99]
KdrKinase insert domain receptor or foetal liver kinase 1 (FLK1); VEGFR2; CD309Receptor tyrosine kinaseEndothelial cells, Kdr+ developmental cardiovascular progenitor Transduction of VEGF-A effects [48,49,75,100]
Klf4Krüppel-like factor 4Member of the Krüppel-like family of transcription factorsStem cells, endothelial cells, fibroblasts Pluripotency; angiogenesis; embryonic vasculogenesis; myofibroblast differentiation [63,75,101,102,103]
MedagMesenteric oestrogen-dependent adipogenesis proteinMember of the sex-steroid-regulated mesenteric oestrogen-dependent adipogenesis proteinsCardiac fibroblasts “1”Adipogenesis; glucose uptake; interacts with the fatty acid transporter CD36, which is involved in the uptake of apoptotic material[26,104,105]
Mef2aMyocyte-specific enhancer factor 2ATranscription factor of the MEF2 familyCardiomyocytes, cardiac fibroblasts, endothelial cells, smooth muscle cells, macrophages, and pericytesCardiogenesis; vasculogenesis[6,75,106,107]
Mef2cMyocyte-specific enhancer factor 2C or MADS box transcription enhancer factor 2Transcription factor of the MEF2 familyCardiomyocytes, cardiac fibroblasts, endothelial cells, smooth muscle cells, macrophages, and pericytesCardiogenesis; vasculogenesis[6,24,25,75,90,108,109]
Mesp1Mesoderm Posterior Transcription Factor 1Transcription factor of the basic helix-loop-helix familyMesodermDevelopment of cardiac mesoderm[110]
Mrc1Mannose receptor C-type 1 or CD206Transmembrane glycoproteinMacrophages (used as an M2 marker)Mediates the endocytic functions of macrophages and the DNA replication checkpoint[26,75,111,112,113]
Ms4a4dMembrane-spanning 4-domains subfamily A member 4DMember of the membrane-spanning 4A (MS4A) familyCardiac fibroblasts “1”, reported to be expressed in M2 macrophages May play a role as an adaptor protein to facilitate intracellular protein–protein interactions. Its functionality is still not fully understood[26,114,115]
Myh6Myosin heavy chain 6 or αMHCHexameric ATPase cellular motor proteinPredominantly atrial cardiomyocytesCardiogenesis; force generation and muscle contraction[116]
Myl2Myosin light chain 2Hexameric ATPase cellular motor proteinPredominantly ventricular cardiomyocytesCardiogenesis; force generation and muscle contraction[116]
NanogNanog HomeoboxTranscription factor of the Nanog homeobox familyStem cellsPluripotency; tumourigenicity[64,65,117]
Ng2Neuron-glial antigen 2 or chondroitin sulphate proteoglycan 4Transmembrane proteoglycanPericytes, smooth muscle cellsCo-receptor in conjunction with PDGFRα; angiogenesis; cell survival and migration[75,118,119,120]
Nkx2-5NK2 homeobox 5Transcription factor of the NK-2 homeobox familyCardiomyocytesCardiogenesis [75,121]
NppaNatriuretic Peptide AThe natriuretic peptide familyPredominantly atrial cardiomyocytesCardiac hormone involved in regulating blood volume and pressure and cardiovascular homeostasis[122]
Pou5f1Octamer-binding transcription factor 4 (Oct4) or POU class 5 homeobox 1Transcription factor of the homeodomain POU (Pit-Oct-Unc) family.Stem cellsPluripotency; tumourigenicity[123,124]
PdgfraPlatelet-derived growth factor receptor αReceptor tyrosine kinaseFibroblasts, defines the SCA1+ SP+ population (CPCs)Development of mesenchymal cell types; cardiogenesis[6,75,125,126,127]
PdgfrbPlatelet-derived growth factor receptor βReceptor tyrosine kinasePericytes, fibroblasts, endothelial cells, smooth muscle cellsDevelopment of mesenchymal cell types; regulation of autophagic processes; cell proliferation and survival; adult mammalian cardiomyocyte proliferation; cardiogenesis[75,127,128,129,130,131,132,133]
Plp1Proteolipid protein 1Myelin proteolipid proteinSchwann cells, endothelial cells, smooth muscle cells, pericytes and macrophagesMyelination[134]
Prg4Proteoglycan 4Mucinous glycoproteinCardiac fibroblasts “2”Ligand for CD44 receptor, ECM constituent conferring compression resistance[26,135,136]
Ptprc (Cd45)Protein tyrosine phosphatase, receptor type, CTransmembrane glycoproteinHaematopoietic cells (except erythrocytes and plasma cells)Haematopoietic cell activation and differentiation, and immune function[137,138,139]
Ly6aStem cell antigen 1 (SCA1) or lymphocyte antigen 6 complex Glycosyl phosphatidylinositol-anchored cell surface protein of the LY6 gene familyHSCs, fibroblasts, endothelial cells, CPCsTumourigenicity; cell migration; HSC self-renewal and fate determination [6,75,140,141,142,143]
Tbx20T-box 20Transcription factor of the T-box familyCardiomyocytes, cardiac pericytes and fibroblastsCardiogenesis[6,75]
Tbx5T-box 5Transcription factor of the T-box familyCardiomyocytes, cardiac fibroblastsCardiogenesis[24,25,90]
Tcf21Transcription factor 21Transcription factor of the basic helix-loop-helix familyEpicardium, Cardiac fibroblasts “1”Initiation of epicardial EMT for fibroblast development; proepicardial cell specification[26,54,144]
TertTelomerase reverse transcriptaseMember of the reverse transcriptase familyStem and progenitor cellsCellular immortalisation tumourigenicity; cell proliferation[145,146]
VimVimentin or fibroblast intermediate filamentType III intermediate filament proteinFibroblasts, endothelial cells, smooth muscle cells, Schwann cellsMaintains cellular integrity; EMT; protective role against nuclear rupture and DNA damage during cell migration.[42,75]
Vwfvon Willebrand factorAdhesive plasma glycoproteinEndothelial cellsPlatelet adhesion and aggregation[147]
Wif1WNT inhibitory factor 1Lipid-binding proteinCardiac fibroblasts “2”Mesoderm segmentation; cardiogenesis[26,148]
Wt1Wilms tumour 1Transcription factor with proline/glutamine-rich DNA-binding domainEpicardium, fibroblasts, endothelial cells, macrophagesEpicardial EMT; vasculogenesis[24,59,60,149,150]
Acta2Alpha smooth muscle actin (αSMA) or Actin alpha 2Member of the globular Actin protein family Smooth muscle cells, myofibroblasts, pericytesCell motility and contractility [41,151]

References

  1. Ali, S.R.; Hippenmeyer, S.; Saadat, L.V.; Luo, L.; Weissman, I.L.; Ardehali, R. Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc. Natl. Acad. Sci. USA 2014, 111, 8850–8855. [Google Scholar] [CrossRef]
  2. Kimura, W.; Xiao, F.; Canseco, D.C.; Muralidhar, S.; Thet, S.; Zhang, H.M.; Abderrahman, Y.; Chen, R.; Garcia, J.A.; Shelton, J.M.; et al. Corrigendum: Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart. Nature 2016, 532, 268. [Google Scholar] [CrossRef]
  3. Senyo, S.E.; Steinhauser, M.L.; Pizzimenti, C.L.; Yang, V.K.; Cai, L.; Wang, M.; Wu, T.D.; Guerquin-Kern, J.L.; Lechene, C.P.; Lee, R.T. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013, 493, 433–436. [Google Scholar] [CrossRef]
  4. Hierlihy, A.M.; Seale, P.; Lobe, C.G.; Rudnicki, M.A.; Megeney, L.A. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 2002, 530, 239–243. [Google Scholar] [CrossRef] [PubMed]
  5. Oh, H.; Bradfute, S.B.; Gallardo, T.D.; Nakamura, T.; Gaussin, V.; Mishina, Y.; Pocius, J.; Michael, L.H.; Behringer, R.R.; Garry, D.J.; et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 2003, 100, 12313–12318. [Google Scholar] [CrossRef] [PubMed]
  6. Noseda, M.; Harada, M.; McSweeney, S.; Leja, T.; Belian, E.; Stuckey, D.J.; Abreu Paiva, M.S.; Habib, J.; Macaulay, I.; de Smith, A.J.; et al. PDGFRalpha demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium. Nat. Commun. 2015, 6, 6930. [Google Scholar] [CrossRef] [PubMed]
  7. Ellison, G.M.; Torella, D.; Dellegrottaglie, S.; Perez-Martinez, C.; Perez de Prado, A.; Vicinanza, C.; Purushothaman, S.; Galuppo, V.; Iaconetti, C.; Waring, C.D.; et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J. Am. Coll. Cardiol. 2011, 58, 977–986. [Google Scholar] [CrossRef]
  8. Vicinanza, C.; Aquila, I.; Scalise, M.; Cristiano, F.; Marino, F.; Cianflone, E.; Mancuso, T.; Marotta, P.; Sacco, W.; Lewis, F.C.; et al. Adult cardiac stem cells are multipotent and robustly myogenic: C-kit expression is necessary but not sufficient for their identification. Cell Death Differ. 2017, 24, 2101–2116. [Google Scholar] [CrossRef]
  9. Laugwitz, K.L.; Moretti, A.; Lam, J.; Gruber, P.; Chen, Y.; Woodard, S.; Lin, L.Z.; Cai, C.L.; Lu, M.M.; Reth, M.; et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433, 647–653. [Google Scholar] [CrossRef]
  10. Weinberger, F.; Mehrkens, D.; Friedrich, F.W.; Stubbendorff, M.; Hua, X.; Muller, J.C.; Schrepfer, S.; Evans, S.M.; Carrier, L.; Eschenhagen, T. Localization of Islet-1-positive cells in the healthy and infarcted adult murine heart. Circ. Res. 2012, 110, 1303–1310. [Google Scholar] [CrossRef]
  11. Messina, E.; De Angelis, L.; Frati, G.; Morrone, S.; Chimenti, S.; Fiordaliso, F.; Salio, M.; Battaglia, M.; Latronico, M.V.; Coletta, M.; et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 2004, 95, 911–921. [Google Scholar] [CrossRef] [PubMed]
  12. Smith, R.R.; Barile, L.; Cho, H.C.; Leppo, M.K.; Hare, J.M.; Messina, E.; Giacomello, A.; Abraham, M.R.; Marban, E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115, 896–908. [Google Scholar] [CrossRef]
  13. Smart, N.; Bollini, S.; Dube, K.N.; Vieira, J.M.; Zhou, B.; Davidson, S.; Yellon, D.; Riegler, J.; Price, A.N.; Lythgoe, M.F.; et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 2011, 474, 640–644. [Google Scholar] [CrossRef] [PubMed]
  14. Alonaizan, R.; Carr, C. Cardiac regeneration following myocardial infarction: The need for regeneration and a review of cardiac stromal cell populations used for transplantation. Biochem. Soc. Trans. 2022, 50, 269–281. [Google Scholar] [CrossRef]
  15. Eschenhagen, T.; Bolli, R.; Braun, T.; Field, L.J.; Fleischmann, B.K.; Frisen, J.; Giacca, M.; Hare, J.M.; Houser, S.; Lee, R.T.; et al. Cardiomyocyte Regeneration: A Consensus Statement. Circulation 2017, 136, 680–686. [Google Scholar] [CrossRef]
  16. Li, Y.; Lv, Z.; He, L.; Huang, X.; Zhang, S.; Zhao, H.; Pu, W.; Li, Y.; Yu, W.; Zhang, L.; et al. Genetic Tracing Identifies Early Segregation of the Cardiomyocyte and Nonmyocyte Lineages. Circ. Res. 2019, 125, 343–355. [Google Scholar] [CrossRef] [PubMed]
  17. Carr, C.A.; Stuckey, D.J.; Tan, J.J.; Tan, S.C.; Gomes, R.S.; Camelliti, P.; Messina, E.; Giacomello, A.; Ellison, G.M.; Clarke, K. Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks—An MRI study. PLoS ONE 2011, 6, e25669. [Google Scholar] [CrossRef]
  18. Lee, S.T.; White, A.J.; Matsushita, S.; Malliaras, K.; Steenbergen, C.; Zhang, Y.; Li, T.S.; Terrovitis, J.; Yee, K.; Simsir, S.; et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J. Am. Coll. Cardiol. 2011, 57, 455–465. [Google Scholar] [CrossRef]
  19. Caplan, A.I. All MSCs are pericytes? Cell Stem Cell 2008, 3, 229–230. [Google Scholar] [CrossRef]
  20. Denu, R.A.; Nemcek, S.; Bloom, D.D.; Goodrich, A.D.; Kim, J.; Mosher, D.F.; Hematti, P. Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable. Acta Haematol. 2016, 136, 85–97. [Google Scholar] [CrossRef]
  21. Hematti, P. Mesenchymal stromal cells and fibroblasts: A case of mistaken identity? Cytotherapy 2012, 14, 516–521. [Google Scholar] [CrossRef] [PubMed]
  22. Murray, I.R.; Peault, B. Q&A: Mesenchymal stem cells—Where do they come from and is it important? BMC Biol. 2015, 13, 99. [Google Scholar] [CrossRef]
  23. Soundararajan, M.; Kannan, S. Fibroblasts and mesenchymal stem cells: Two sides of the same coin? J. Cell. Physiol. 2018, 233, 9099–9109. [Google Scholar] [CrossRef]
  24. Furtado, M.B.; Costa, M.W.; Pranoto, E.A.; Salimova, E.; Pinto, A.R.; Lam, N.T.; Park, A.; Snider, P.; Chandran, A.; Harvey, R.P.; et al. Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ. Res. 2014, 114, 1422–1434. [Google Scholar] [CrossRef]
  25. Furtado, M.B.; Nim, H.T.; Gould, J.A.; Costa, M.W.; Rosenthal, N.A.; Boyd, S.E. Microarray profiling to analyse adult cardiac fibroblast identity. Genom. Data 2014, 2, 345–350. [Google Scholar] [CrossRef] [PubMed]
  26. Skelly, D.A.; Squiers, G.T.; McLellan, M.A.; Bolisetty, M.T.; Robson, P.; Rosenthal, N.A.; Pinto, A.R. Single-Cell Transcriptional Profiling Reveals Cellular Diversity and Intercommunication in the Mouse Heart. Cell Rep. 2018, 22, 600–610. [Google Scholar] [CrossRef]
  27. Gharaibeh, B.; Lu, A.; Tebbets, J.; Zheng, B.; Feduska, J.; Crisan, M.; Peault, B.; Cummins, J.; Huard, J. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat. Protoc. 2008, 3, 1501–1509. [Google Scholar] [CrossRef]
  28. Okada, M.; Payne, T.R.; Drowley, L.; Jankowski, R.J.; Momoi, N.; Beckman, S.; Chen, W.C.; Keller, B.B.; Tobita, K.; Huard, J. Human skeletal muscle cells with a slow adhesion rate after isolation and an enhanced stress resistance improve function of ischemic hearts. Mol. Ther. 2012, 20, 138–145. [Google Scholar] [CrossRef]
  29. Malandraki-Miller, S.; Lopez, C.A.; Alonaizan, R.; Purnama, U.; Perbellini, F.; Pakzad, K.; Carr, C.A. Metabolic flux analyses to assess the differentiation of adult cardiac progenitors after fatty acid supplementation. Stem Cell Res. 2019, 38, 101458. [Google Scholar] [CrossRef]
  30. Goumans, M.J.; de Boer, T.P.; Smits, A.M.; van Laake, L.W.; van Vliet, P.; Metz, C.H.; Korfage, T.H.; Kats, K.P.; Hochstenbach, R.; Pasterkamp, G.; et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res. 2007, 1, 138–149. [Google Scholar] [CrossRef]
  31. Smits, A.M.; van Vliet, P.; Metz, C.H.; Korfage, T.; Sluijter, J.P.; Doevendans, P.A.; Goumans, M.J. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: An in vitro model for studying human cardiac physiology and pathophysiology. Nat. Protoc. 2009, 4, 232–243. [Google Scholar] [CrossRef]
  32. Lopaschuk, G.D.; Jaswal, J.S. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J. Cardiovasc. Pharmacol. 2010, 56, 130–140. [Google Scholar] [CrossRef] [PubMed]
  33. Lekkos, K.; Hu, Z.; Nguyen, P.D.; Honkoop, H.; Sengul, E.; Alonaizan, R.; Koth, J.; Ying, J.; Lemieux, M.E.; Kenward, A.; et al. Oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term fish heart regeneration. Nat. Cardiovasc. Res. 2025, 4, 1363–1380. [Google Scholar] [CrossRef] [PubMed]
  34. Alonaizan, R.; Purnama, U.; Malandraki-Miller, S.; Gunadasa-Rohling, M.; Lewis, A.; Smart, N.; Carr, C. MicroRNA-210 Enhances Cell Survival and Paracrine Potential for Cardiac Cell Therapy While Targeting Mitophagy. J. Funct. Biomater. 2025, 16, 147. [Google Scholar] [CrossRef]
  35. Claycomb, W.C.; Lanson, N.A., Jr.; Stallworth, B.S.; Egeland, D.B.; Delcarpio, J.B.; Bahinski, A.; Izzo, N.J., Jr. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. USA 1998, 95, 2979–2984. [Google Scholar] [CrossRef] [PubMed]
  36. Lu, C.; Shi, Y.; Wang, Z.; Song, Z.; Zhu, M.; Cai, Q.; Chen, T. Serum starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway. FEBS Lett. 2008, 582, 2703–2708. [Google Scholar] [CrossRef]
  37. Ye, J.; Boyle, A.; Shih, H.; Sievers, R.E.; Zhang, Y.; Prasad, M.; Su, H.; Zhou, Y.; Grossman, W.; Bernstein, H.S.; et al. Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury. PLoS ONE 2012, 7, e30329. [Google Scholar] [CrossRef]
  38. Huang, Y.C.; Yang, Z.M.; Chen, X.H.; Tan, M.Y.; Wang, J.; Li, X.Q.; Xie, H.Q.; Deng, L. Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev. Rep. 2009, 5, 247–255. [Google Scholar] [CrossRef]
  39. Peng, L.; Jia, Z.; Yin, X.; Zhang, X.; Liu, Y.; Chen, P.; Ma, K.; Zhou, C. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev. 2008, 17, 761–773. [Google Scholar] [CrossRef]
  40. Liberio, M.S.; Sadowski, M.C.; Soekmadji, C.; Davis, R.A.; Nelson, C.C. Differential effects of tissue culture coating substrates on prostate cancer cell adherence, morphology and behavior. PLoS ONE 2014, 9, e112122. [Google Scholar] [CrossRef]
  41. Rockey, D.C.; Weymouth, N.; Shi, Z. Smooth muscle alpha actin (Acta2) and myofibroblast function during hepatic wound healing. PLoS ONE 2013, 8, e77166. [Google Scholar] [CrossRef]
  42. Patteson, A.E.; Vahabikashi, A.; Pogoda, K.; Adam, S.A.; Mandal, K.; Kittisopikul, M.; Sivagurunathan, S.; Goldman, A.; Goldman, R.D.; Janmey, P.A. Vimentin protects cells against nuclear rupture and DNA damage during migration. J. Cell Biol. 2019, 218, 4079–4092. [Google Scholar] [CrossRef]
  43. Kuznetsov, A.V.; Javadov, S.; Sickinger, S.; Frotschnig, S.; Grimm, M. H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation. Biochim. Biophys. Acta 2015, 1853, 276–284. [Google Scholar] [CrossRef]
  44. Geraghty, R.J.; Capes-Davis, A.; Davis, J.M.; Downward, J.; Freshney, R.I.; Knezevic, I.; Lovell-Badge, R.; Masters, J.R.; Meredith, J.; Stacey, G.N.; et al. Guidelines for the use of cell lines in biomedical research. Br. J. Cancer 2014, 111, 1021–1046. [Google Scholar] [CrossRef] [PubMed]
  45. Volz, K.S.; Jacobs, A.H.; Chen, H.I.; Poduri, A.; McKay, A.S.; Riordan, D.P.; Kofler, N.; Kitajewski, J.; Weissman, I.; Red-Horse, K. Pericytes are progenitors for coronary artery smooth muscle. eLife 2015, 4, e10036. [Google Scholar] [CrossRef]
  46. Moretti, A.; Caron, L.; Nakano, A.; Lam, J.T.; Bernshausen, A.; Chen, Y.; Qyang, Y.; Bu, L.; Sasaki, M.; Martin-Puig, S.; et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127, 1151–1165. [Google Scholar] [CrossRef]
  47. Lam, J.T.; Moretti, A.; Laugwitz, K.L. Multipotent progenitor cells in regenerative cardiovascular medicine. Pediatr. Cardiol. 2009, 30, 690–698. [Google Scholar] [CrossRef]
  48. Kattman, S.J.; Huber, T.L.; Keller, G.M. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 2006, 11, 723–732. [Google Scholar] [CrossRef] [PubMed]
  49. Motoike, T.; Markham, D.W.; Rossant, J.; Sato, T.N. Evidence for novel fate of Flk1+ progenitor: Contribution to muscle lineage. Genesis 2003, 35, 153–159. [Google Scholar] [CrossRef] [PubMed]
  50. Mekala, S.R.; Worsdorfer, P.; Bauer, J.; Stoll, O.; Wagner, N.; Reeh, L.; Loew, K.; Eckner, G.; Kwok, C.K.; Wischmeyer, E.; et al. Generation of Cardiomyocytes From Vascular Adventitia-Resident Stem Cells. Circ. Res. 2018, 123, 686–699. [Google Scholar] [CrossRef]
  51. Zampetaki, A.; Kirton, J.P.; Xu, Q. Vascular repair by endothelial progenitor cells. Cardiovasc. Res. 2008, 78, 413–421. [Google Scholar] [CrossRef]
  52. Gao, L.; Zhang, H.; Cui, J.; Pei, L.; Huang, S.; Mao, Y.; Liu, Z.; Wei, K.; Zhu, H. Single-cell transcriptomics of cardiac progenitors reveals functional subpopulations and their cooperative crosstalk in cardiac repair. Protein Cell 2021, 12, 152–157. [Google Scholar] [CrossRef] [PubMed]
  53. Masters, M.; Riley, P.R. The epicardium signals the way towards heart regeneration. Stem Cell Res. 2014, 13, 683–692. [Google Scholar] [CrossRef]
  54. Acharya, A.; Baek, S.T.; Huang, G.; Eskiocak, B.; Goetsch, S.; Sung, C.Y.; Banfi, S.; Sauer, M.F.; Olsen, G.S.; Duffield, J.S.; et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012, 139, 2139–2149. [Google Scholar] [CrossRef]
  55. Braitsch, C.M.; Kanisicak, O.; van Berlo, J.H.; Molkentin, J.D.; Yutzey, K.E. Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J. Mol. Cell Cardiol. 2013, 65, 108–119. [Google Scholar] [CrossRef] [PubMed]
  56. Kanisicak, O.; Khalil, H.; Ivey, M.J.; Karch, J.; Maliken, B.D.; Correll, R.N.; Brody, M.J.; Lin, S.-C.J.; Aronow, B.J.; Tallquist, M.D.; et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat. Commun. 2016, 7, 12260. [Google Scholar] [CrossRef] [PubMed]
  57. Armstrong, J.F.; Pritchard-Jones, K.; Bickmore, W.A.; Hastie, N.D.; Bard, J.B. The expression of the Wilms’ tumour gene, WT1, in the developing mammalian embryo. Mech. Dev. 1993, 40, 85–97. [Google Scholar] [CrossRef]
  58. Carmona, R.; Gonzalez-Iriarte, M.; Perez-Pomares, J.M.; Munoz-Chapuli, R. Localization of the Wilm’s tumour protein WT1 in avian embryos. Cell Tissue Res. 2001, 303, 173–186. [Google Scholar] [CrossRef]
  59. Duim, S.N.; Kurakula, K.; Goumans, M.J.; Kruithof, B.P. Cardiac endothelial cells express Wilms’ tumor-1: Wt1 expression in the developing, adult and infarcted heart. J. Mol. Cell Cardiol. 2015, 81, 127–135. [Google Scholar] [CrossRef]
  60. Sanz-Morejon, A.; Garcia-Redondo, A.B.; Reuter, H.; Marques, I.J.; Bates, T.; Galardi-Castilla, M.; Grosse, A.; Manig, S.; Langa, X.; Ernst, A.; et al. Wilms Tumor 1b Expression Defines a Pro-regenerative Macrophage Subtype and Is Required for Organ Regeneration in the Zebrafish. Cell Rep. 2019, 28, 1296–1306 e1296. [Google Scholar] [CrossRef]
  61. Tan, S.C.; Gomes, R.S.; Yeoh, K.K.; Perbellini, F.; Malandraki-Miller, S.; Ambrose, L.; Heather, L.C.; Faggian, G.; Schofield, C.J.; Davies, K.E.; et al. Preconditioning of Cardiosphere-Derived Cells With Hypoxia or Prolyl-4-Hydroxylase Inhibitors Increases Stemness and Decreases Reliance on Oxidative Metabolism. Cell Transplant. 2016, 25, 35–53. [Google Scholar] [CrossRef]
  62. Zangrossi, S.; Marabese, M.; Broggini, M.; Giordano, R.; D’Erasmo, M.; Montelatici, E.; Intini, D.; Neri, A.; Pesce, M.; Rebulla, P.; et al. Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 2007, 25, 1675–1680. [Google Scholar] [CrossRef] [PubMed]
  63. Ghaleb, A.M.; Yang, V.W. Kruppel-like factor 4 (KLF4): What we currently know. Gene 2017, 611, 27–37. [Google Scholar] [CrossRef] [PubMed]
  64. Ambady, S.; Malcuit, C.; Kashpur, O.; Kole, D.; Holmes, W.F.; Hedblom, E.; Page, R.L.; Dominko, T. Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. Int. J. Dev. Biol. 2010, 54, 1743–1754. [Google Scholar] [CrossRef] [PubMed]
  65. Piazzolla, D.; Palla, A.R.; Pantoja, C.; Canamero, M.; de Castro, I.P.; Ortega, S.; Gomez-Lopez, G.; Dominguez, O.; Megias, D.; Roncador, G.; et al. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat. Commun. 2014, 5, 4226. [Google Scholar] [CrossRef]
  66. Sun, L.; Chiang, J.Y.; Choi, J.Y.; Xiong, Z.M.; Mao, X.; Collins, F.S.; Hodes, R.J.; Cao, K. Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts. Proc. Natl. Acad. Sci. USA 2019, 116, 18983–18993. [Google Scholar] [CrossRef]
  67. Wang, G.; Zhou, H.; Gu, Z.; Gao, Q.; Shen, G. Oct4 promotes cancer cell proliferation and migration and leads to poor prognosis associated with the survivin/STAT3 pathway in hepatocellular carcinoma. Oncol. Rep. 2018, 40, 979–987. [Google Scholar] [CrossRef]
  68. White, M.G.; Al-Turaifi, H.R.; Holliman, G.N.; Aldibbiat, A.; Mahmoud, A.; Shaw, J.A. Pluripotency-associated stem cell marker expression in proliferative cell cultures derived from adult human pancreas. J. Endocrinol. 2011, 211, 169–176. [Google Scholar] [CrossRef]
  69. Marino, S.; Alheijailan, R.; Alonaizan, R.; Gabetti, S.; Massai, D.; Pesce, M. Cardiac Tissue Bioprinting: Integrating Structure and Functions Through Biomimetic Design, Bioinks, and Stimulation. Gels 2025, 11, 593. [Google Scholar] [CrossRef]
  70. Cannarile, M.A.; Weisser, M.; Jacob, W.; Jegg, A.M.; Ries, C.H.; Ruttinger, D. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J. Immunother. Cancer 2017, 5, 53. [Google Scholar] [CrossRef]
  71. Plein, A.; Fantin, A.; Denti, L.; Pollard, J.W.; Ruhrberg, C. Erythro-myeloid progenitors contribute endothelial cells to blood vessels. Nature 2018, 562, 223–228. [Google Scholar] [CrossRef] [PubMed]
  72. Li, R.; Chen, B.; Kubota, A.; Hanna, A.; Humeres, C.; Hernandez, S.C.; Liu, Y.; Ma, R.; Tuleta, I.; Huang, S.; et al. Protective effects of macrophage-specific integrin α5 in myocardial infarction are associated with accentuated angiogenesis. Nat. Commun. 2023, 14, 7555. [Google Scholar] [CrossRef]
  73. Li, R.; Hanna, A.; Huang, S.; Hernandez, S.C.; Tuleta, I.; Kubota, A.; Humeres, C.; Chen, B.; Liu, Y.; Zheng, D.; et al. Macrophages in the infarcted heart acquire a fibrogenic phenotype, expressing matricellular proteins, but do not undergo fibroblast conversion. J. Mol. Cell. Cardiol. 2024, 196, 152–167. [Google Scholar] [CrossRef]
  74. Feng, R.; Desbordes, S.C.; Xie, H.; Tillo, E.S.; Pixley, F.; Stanley, E.R.; Graf, T. PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc. Natl. Acad. Sci. USA 2008, 105, 6057–6062. [Google Scholar] [CrossRef]
  75. Franzen, O.; Gan, L.M.; Bjorkegren, J.L.M. PanglaoDB: A web server for exploration of mouse and human single-cell RNA sequencing data. Database 2019, 2019, baz046. [Google Scholar] [CrossRef]
  76. Huebener, P.; Abou-Khamis, T.; Zymek, P.; Bujak, M.; Ying, X.; Chatila, K.; Haudek, S.; Thakker, G.; Frangogiannis, N.G. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J. Immunol. 2008, 180, 2625–2633. [Google Scholar] [CrossRef]
  77. Sneath, R.J.; Mangham, D.C. The normal structure and function of CD44 and its role in neoplasia. Mol. Pathol. 1998, 51, 191–200. [Google Scholar] [CrossRef]
  78. Suleiman, M.; Abdulrahman, N.; Yalcin, H.; Mraiche, F. The role of CD44, hyaluronan and NHE1 in cardiac remodeling. Life Sci. 2018, 209, 197–201. [Google Scholar] [CrossRef]
  79. Harris, E.S.; Nelson, W.J. VE-cadherin: At the front, center, and sides of endothelial cell organization and function. Curr. Opin. Cell Biol. 2010, 22, 651–658. [Google Scholar] [CrossRef] [PubMed]
  80. Pan, X.; Chen, Z.; Huang, R.; Yao, Y.; Ma, G. Transforming growth factor beta1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts. PLoS ONE 2013, 8, e60335. [Google Scholar] [CrossRef]
  81. Sandri, T.L.; Andrade, F.A.; Lidani, K.C.F.; Einig, E.; Boldt, A.B.W.; Mordmuller, B.; Esen, M.; Messias-Reason, I.J. Human collectin-11 (COLEC11) and its synergic genetic interaction with MASP2 are associated with the pathophysiology of Chagas Disease. PLoS Neglected Trop. Dis. 2019, 13, e0007324. [Google Scholar] [CrossRef]
  82. Selman, L.; Hansen, S. Structure and function of collectin liver 1 (CL-L1) and collectin 11 (CL-11, CL-K1). Immunobiology 2012, 217, 851–863. [Google Scholar] [CrossRef]
  83. Sehgal, A.; Donaldson, D.S.; Pridans, C.; Sauter, K.A.; Hume, D.A.; Mabbott, N.A. The role of CSF1R-dependent macrophages in control of the intestinal stem-cell niche. Nat. Commun. 2018, 9, 1272. [Google Scholar] [CrossRef] [PubMed]
  84. Lee, M.; Lee, Y.; Song, J.; Lee, J.; Chang, S.Y. Tissue-specific Role of CX(3)CR1 Expressing Immune Cells and Their Relationships with Human Disease. Immune Netw. 2018, 18, e5. [Google Scholar] [CrossRef] [PubMed]
  85. Zheng, J.; Yang, M.; Shao, J.; Miao, Y.; Han, J.; Du, J. Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis. Mol. Cancer 2013, 12, 141. [Google Scholar] [CrossRef] [PubMed]
  86. Leitinger, B. Discoidin domain receptor functions in physiological and pathological conditions. Int. Rev. Cell Mol. Biol. 2014, 310, 39–87. [Google Scholar] [CrossRef]
  87. Valiathan, R.R.; Marco, M.; Leitinger, B.; Kleer, C.G.; Fridman, R. Discoidin domain receptor tyrosine kinases: New players in cancer progression. Cancer Metastasis Rev. 2012, 31, 295–321. [Google Scholar] [CrossRef]
  88. Molkentin, J.D.; Lin, Q.; Duncan, S.A.; Olson, E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997, 11, 1061–1072. [Google Scholar] [CrossRef]
  89. Watt, A.J.; Battle, M.A.; Li, J.; Duncan, S.A. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc. Natl. Acad. Sci. USA 2004, 101, 12573–12578. [Google Scholar] [CrossRef]
  90. Xin, M.; Olson, E.N.; Bassel-Duby, R. Mending broken hearts: Cardiac development as a basis for adult heart regeneration and repair. Nat. Rev. Mol. Cell Biol. 2013, 14, 529–541. [Google Scholar] [CrossRef]
  91. Barnes, R.M.; Firulli, B.A.; VanDusen, N.J.; Morikawa, Y.; Conway, S.J.; Cserjesi, P.; Vincentz, J.W.; Firulli, A.B. Hand2 loss-of-function in Hand1-expressing cells reveals distinct roles in epicardial and coronary vessel development. Circ. Res. 2011, 108, 940–949. [Google Scholar] [CrossRef]
  92. McFadden, D.G.; Barbosa, A.C.; Richardson, J.A.; Schneider, M.D.; Srivastava, D.; Olson, E.N. The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner. Development 2005, 132, 189–201. [Google Scholar] [CrossRef]
  93. Thattaliyath, B.D.; Livi, C.B.; Steinhelper, M.E.; Toney, G.M.; Firulli, A.B. HAND1 and HAND2 are expressed in the adult-rodent heart and are modulated during cardiac hypertrophy. Biochem. Biophys. Res. Commun. 2002, 297, 870–875. [Google Scholar] [CrossRef]
  94. Tsuchihashi, T.; Maeda, J.; Shin, C.H.; Ivey, K.N.; Black, B.L.; Olson, E.N.; Yamagishi, H.; Srivastava, D. Hand2 function in second heart field progenitors is essential for cardiogenesis. Dev. Biol. 2011, 351, 62–69. [Google Scholar] [CrossRef] [PubMed]
  95. Cai, C.L.; Liang, X.; Shi, Y.; Chu, P.H.; Pfaff, S.L.; Chen, J.; Evans, S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 2003, 5, 877–889. [Google Scholar] [CrossRef] [PubMed]
  96. Glasscock, E. Kv1.1 channel subunits in the control of neurocardiac function. Channels 2019, 13, 299–307. [Google Scholar] [CrossRef] [PubMed]
  97. Miki, T.; Suzuki, M.; Shibasaki, T.; Uemura, H.; Sato, T.; Yamaguchi, K.; Koseki, H.; Iwanaga, T.; Nakaya, H.; Seino, S. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat. Med. 2002, 8, 466–472. [Google Scholar] [CrossRef]
  98. Tester, D.J.; Tan, B.H.; Medeiros-Domingo, A.; Song, C.; Makielski, J.C.; Ackerman, M.J. Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome. Circ. Cardiovasc. Genet. 2011, 4, 510–515. [Google Scholar] [CrossRef]
  99. Zingman, L.V.; Alekseev, A.E.; Hodgson-Zingman, D.M.; Terzic, A. ATP-sensitive potassium channels: Metabolic sensing and cardioprotection. J. Appl. Physiol. 2007, 103, 1888–1893. [Google Scholar] [CrossRef]
  100. Simons, M.; Gordon, E.; Claesson-Welsh, L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat. Rev. Mol. Cell Biol. 2016, 17, 611–625. [Google Scholar] [CrossRef]
  101. Chiplunkar, A.R.; Curtis, B.C.; Eades, G.L.; Kane, M.S.; Fox, S.J.; Haar, J.L.; Lloyd, J.A. The Kruppel-like factor 2 and Kruppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis. BMC Dev. Biol. 2013, 13, 40. [Google Scholar] [CrossRef] [PubMed]
  102. Zhang, P.; Andrianakos, R.; Yang, Y.; Liu, C.; Lu, W. Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J. Biol. Chem. 2010, 285, 9180–9189. [Google Scholar] [CrossRef]
  103. Zhang, Y.; Wang, Y.; Liu, Y.; Wang, N.; Qi, Y.; Du, J. Kruppel-like factor 4 transcriptionally regulates TGF-beta1 and contributes to cardiac myofibroblast differentiation. PLoS ONE 2013, 8, e63424. [Google Scholar] [CrossRef]
  104. Stolzing, A.; Grune, T. Neuronal apoptotic bodies: Phagocytosis and degradation by primary microglial cells. FASEB J. 2004, 18, 743–745. [Google Scholar] [CrossRef] [PubMed]
  105. Zhang, H.; Chen, X.; Sairam, M.R. Novel genes of visceral adiposity: Identification of mouse and human mesenteric estrogen-dependent adipose (MEDA)-4 gene and its adipogenic function. Endocrinology 2012, 153, 2665–2676. [Google Scholar] [CrossRef]
  106. Subramanian, S.V.; Nadal-Ginard, B. Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell lineages during mouse embryogenesis. Mech. Dev. 1996, 57, 103–112. [Google Scholar] [CrossRef]
  107. Wang, L.; Fan, C.; Topol, S.E.; Topol, E.J.; Wang, Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003, 302, 1578–1581. [Google Scholar] [CrossRef]
  108. Bi, W.; Drake, C.J.; Schwarz, J.J. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol. 1999, 211, 255–267. [Google Scholar] [CrossRef]
  109. Lin, Q.; Schwarz, J.; Bucana, C.; Olson, E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997, 276, 1404–1407. [Google Scholar] [CrossRef]
  110. Kitajima, S.; Takagi, A.; Inoue, T.; Saga, Y. MesP1 and MesP2 are essential for the development of cardiac mesoderm. Development 2000, 127, 3215–3226. [Google Scholar] [CrossRef]
  111. Komata, M.; Bando, M.; Araki, H.; Shirahige, K. The direct binding of Mrc1, a checkpoint mediator, to Mcm6, a replication helicase, is essential for the replication checkpoint against methyl methanesulfonate-induced stress. Mol. Cell. Biol. 2009, 29, 5008–5019. [Google Scholar] [CrossRef] [PubMed]
  112. Staines, K.; Hunt, L.G.; Young, J.R.; Butter, C. Evolution of an expanded mannose receptor gene family. PLoS ONE 2014, 9, e110330. [Google Scholar] [CrossRef]
  113. Roszer, T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediat. Inflamm. 2015, 2015, 816460. [Google Scholar] [CrossRef]
  114. Eon Kuek, L.; Leffler, M.; Mackay, G.A.; Hulett, M.D. The MS4A family: Counting past 1, 2 and 3. Immunol. Cell Biol. 2016, 94, 11–23. [Google Scholar] [CrossRef]
  115. Martinez, F.O.; Gordon, S.; Locati, M.; Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J. Immunol. 2006, 177, 7303–7311. [Google Scholar] [CrossRef]
  116. England, J.; Loughna, S. Heavy and light roles: Myosin in the morphogenesis of the heart. Cell. Mol. Life Sci. 2013, 70, 1221–1239. [Google Scholar] [CrossRef] [PubMed]
  117. Gawlik-Rzemieniewska, N.; Bednarek, I. The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biol. Ther. 2016, 17, 1–10. [Google Scholar] [CrossRef] [PubMed]
  118. Ampofo, E.; Schmitt, B.M.; Menger, M.D.; Laschke, M.W. The regulatory mechanisms of NG2/CSPG4 expression. Cell. Mol. Biol. Lett. 2017, 22, 4. [Google Scholar] [CrossRef]
  119. Fukushi, J.; Makagiansar, I.T.; Stallcup, W.B. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol. Biol. Cell 2004, 15, 3580–3590. [Google Scholar] [CrossRef]
  120. Goretzki, L.; Burg, M.A.; Grako, K.A.; Stallcup, W.B. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J. Biol. Chem. 1999, 274, 16831–16837. [Google Scholar] [CrossRef]
  121. Tanaka, M.; Chen, Z.; Bartunkova, S.; Yamasaki, N.; Izumo, S. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 1999, 126, 1269–1280. [Google Scholar] [CrossRef]
  122. Song, W.; Wang, H.; Wu, Q. Atrial natriuretic peptide in cardiovascular biology and disease (NPPA). Gene 2015, 569, 1–6. [Google Scholar] [CrossRef] [PubMed]
  123. Pan, G.J.; Chang, Z.Y.; Scholer, H.R.; Pei, D. Stem cell pluripotency and transcription factor Oct4. Cell Res. 2002, 12, 321–329. [Google Scholar] [CrossRef]
  124. Zeineddine, D.; Hammoud, A.A.; Mortada, M.; Boeuf, H. The Oct4 protein: More than a magic stemness marker. Am. J. Stem Cells 2014, 3, 74–82. [Google Scholar]
  125. El-Rass, S.; Eisa-Beygi, S.; Khong, E.; Brand-Arzamendi, K.; Mauro, A.; Zhang, H.; Clark, K.J.; Ekker, S.C.; Wen, X.Y. Disruption of pdgfra alters endocardial and myocardial fusion during zebrafish cardiac assembly. Biol. Open 2017, 6, 348–357. [Google Scholar] [CrossRef] [PubMed]
  126. Horikawa, S.; Ishii, Y.; Hamashima, T.; Yamamoto, S.; Mori, H.; Fujimori, T.; Shen, J.; Inoue, R.; Nishizono, H.; Itoh, H.; et al. PDGFRalpha plays a crucial role in connective tissue remodeling. Sci. Rep. 2015, 5, 17948. [Google Scholar] [CrossRef] [PubMed]
  127. Kim, J.; Wu, Q.; Zhang, Y.; Wiens, K.M.; Huang, Y.; Rubin, N.; Shimada, H.; Handin, R.I.; Chao, M.Y.; Tuan, T.L.; et al. PDGF signaling is required for epicardial function and blood vessel formation in regenerating zebrafish hearts. Proc. Natl. Acad. Sci. USA 2010, 107, 17206–17210. [Google Scholar] [CrossRef]
  128. Betsholtz, C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor. Rev. 2004, 15, 215–228. [Google Scholar] [CrossRef]
  129. Hsieh, P.C.; Davis, M.E.; Gannon, J.; MacGillivray, C.; Lee, R.T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Investig. 2006, 116, 237–248. [Google Scholar] [CrossRef]
  130. Peng, Y.; Yan, S.; Chen, D.; Cui, X.; Jiao, K. Pdgfrb is a direct regulatory target of TGFbeta signaling in atrioventricular cushion mesenchymal cells. PLoS ONE 2017, 12, e0175791. [Google Scholar] [CrossRef]
  131. Van den Akker, N.M.; Winkel, L.C.; Nisancioglu, M.H.; Maas, S.; Wisse, L.J.; Armulik, A.; Poelmann, R.E.; Lie-Venema, H.; Betsholtz, C.; Gittenberger-de Groot, A.C. PDGF-B signaling is important for murine cardiac development: Its role in developing atrioventricular valves, coronaries, and cardiac innervation. Dev. Dyn. 2008, 237, 494–503. [Google Scholar] [CrossRef]
  132. Wilkinson, S.; O’Prey, J.; Fricker, M.; Ryan, K.M. Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activity. Genes Dev. 2009, 23, 1283–1288. [Google Scholar] [CrossRef]
  133. Yue, Z.; Chen, J.; Lian, H.; Pei, J.; Li, Y.; Chen, X.; Song, S.; Xia, J.; Zhou, B.; Feng, J.; et al. PDGFR-beta Signaling Regulates Cardiomyocyte Proliferation and Myocardial Regeneration. Cell Rep. 2019, 28, 966–978.e4. [Google Scholar] [CrossRef] [PubMed]
  134. Grossi, S.; Regis, S.; Biancheri, R.; Mort, M.; Lualdi, S.; Bertini, E.; Uziel, G.; Boespflug-Tanguy, O.; Simonati, A.; Corsolini, F.; et al. Molecular genetic analysis of the PLP1 gene in 38 families with PLP1-related disorders: Identification and functional characterization of 11 novel PLP1 mutations. Orphanet J. Rare Dis. 2011, 6, 40. [Google Scholar] [CrossRef]
  135. Alquraini, A.; Jamal, M.; Zhang, L.; Schmidt, T.; Jay, G.D.; Elsaid, K.A. The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes. Arthritis Res. Ther. 2017, 19, 89. [Google Scholar] [CrossRef]
  136. Han, L.; Grodzinsky, A.J.; Ortiz, C. Nanomechanics of the Cartilage Extracellular Matrix. Annu. Rev. Mater. Res. 2011, 41, 133–168. [Google Scholar] [CrossRef] [PubMed]
  137. Dawes, R.; Petrova, S.; Liu, Z.; Wraith, D.; Beverley, P.C.; Tchilian, E.Z. Combinations of CD45 isoforms are crucial for immune function and disease. J. Immunol. 2006, 176, 3417–3425. [Google Scholar] [CrossRef] [PubMed]
  138. Hermiston, M.L.; Xu, Z.; Weiss, A. CD45: A critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 2003, 21, 107–137. [Google Scholar] [CrossRef]
  139. Nakano, A.; Harada, T.; Morikawa, S.; Kato, Y. Expression of leukocyte common antigen (CD45) on various human leukemia/lymphoma cell lines. Acta Pathol. Jpn. 1990, 40, 107–115. [Google Scholar] [CrossRef]
  140. Batts, T.D.; Machado, H.L.; Zhang, Y.; Creighton, C.J.; Li, Y.; Rosen, J.M. Stem cell antigen-1 (sca-1) regulates mammary tumor development and cell migration. PLoS ONE 2011, 6, e27841. [Google Scholar] [CrossRef]
  141. Bradfute, S.B.; Graubert, T.A.; Goodell, M.A. Roles of Sca-1 in hematopoietic stem/progenitor cell function. Exp. Hematol. 2005, 33, 836–843. [Google Scholar] [CrossRef]
  142. Ito, C.Y.; Li, C.Y.; Bernstein, A.; Dick, J.E.; Stanford, W.L. Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A-null mice. Blood 2003, 101, 517–523. [Google Scholar] [CrossRef]
  143. Upadhyay, G.; Yin, Y.; Yuan, H.; Li, X.; Derynck, R.; Glazer, R.I. Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling. Proc. Natl. Acad. Sci. USA 2011, 108, 7820–7825. [Google Scholar] [CrossRef] [PubMed]
  144. Tandon, P.; Miteva, Y.V.; Kuchenbrod, L.M.; Cristea, I.M.; Conlon, F.L. Tcf21 regulates the specification and maturation of proepicardial cells. Development 2013, 140, 2409–2421. [Google Scholar] [CrossRef]
  145. Mattson, M.P.; Fu, W.; Zhang, P. Emerging roles for telomerase in regulating cell differentiation and survival: A neuroscientist’s perspective. Mech. Ageing Dev. 2001, 122, 659–671. [Google Scholar] [CrossRef]
  146. Yuan, X.; Larsson, C.; Xu, D. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: Old actors and new players. Oncogene 2019, 38, 6172–6183. [Google Scholar] [CrossRef]
  147. Peyvandi, F.; Garagiola, I.; Baronciani, L. Role of von Willebrand factor in the haemostasis. Blood Transfus. 2011, 9, s3–s8. [Google Scholar] [CrossRef]
  148. Lu, D.; Dong, W.; Zhang, X.; Quan, X.; Bao, D.; Lu, Y.; Zhang, L. WIF1 causes dysfunction of heart in transgenic mice. Transgenic Res. 2013, 22, 1179–1189. [Google Scholar] [CrossRef] [PubMed]
  149. Smits, A.M.; Dronkers, E.; Goumans, M.J. The epicardium as a source of multipotent adult cardiac progenitor cells: Their origin, role and fate. Pharmacol. Res. 2018, 127, 129–140. [Google Scholar] [CrossRef] [PubMed]
  150. Zhao, L.; Borikova, A.L.; Ben-Yair, R.; Guner-Ataman, B.; MacRae, C.A.; Lee, R.T.; Burns, C.G.; Burns, C.E. Notch signaling regulates cardiomyocyte proliferation during zebrafish heart regeneration. Proc. Natl. Acad. Sci. USA 2014, 111, 1403–1408. [Google Scholar] [CrossRef]
  151. Schildmeyer, L.A.; Braun, R.; Taffet, G.; Debiasi, M.; Burns, A.E.; Bradley, A.; Schwartz, R.J. Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J. 2000, 14, 2213–2220. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The CT protocol produces a higher cell yield than CDCs but a similar survival potential. (A) Schematic showing the protocol used to isolate CTs, CDCs, and CFs. The isolation protocols for CTs and CDCs are detailed in the Methods section. As CFs were purchased and not isolated in our laboratory, some information is lacking (e.g., the age of the mice, duration of cell attachment, and composition of the accompanying medium). Illustration created with BioRender.com. (B) Average time to reach 90% confluence at passage 0 and passage 1, as assessed by cell counting, in CTs and CDCs. (C) Cell survival following serum starvation for 3 or 10 days, as assessed by cell counting, in CTs, CDCs, and CFs. Data were analysed using a two-way ANOVA with Tukey’s multiple-comparisons test to determine statistical significance (n = 4, ns = not significant, ** p < 0.01).
Figure 1. The CT protocol produces a higher cell yield than CDCs but a similar survival potential. (A) Schematic showing the protocol used to isolate CTs, CDCs, and CFs. The isolation protocols for CTs and CDCs are detailed in the Methods section. As CFs were purchased and not isolated in our laboratory, some information is lacking (e.g., the age of the mice, duration of cell attachment, and composition of the accompanying medium). Illustration created with BioRender.com. (B) Average time to reach 90% confluence at passage 0 and passage 1, as assessed by cell counting, in CTs and CDCs. (C) Cell survival following serum starvation for 3 or 10 days, as assessed by cell counting, in CTs, CDCs, and CFs. Data were analysed using a two-way ANOVA with Tukey’s multiple-comparisons test to determine statistical significance (n = 4, ns = not significant, ** p < 0.01).
Cells 15 00384 g001
Figure 2. Single-cell analysis reveals enrichment of Tcf21 and low expression of Tbx5 in CTs compared to CDCs and CFs. (A) Expression of 43 genes was analysed at the single-cell level in the four cell populations shown: CTs (n = 55), CDCs (n = 41), and CFs (n = 29) at passage 3, as well as HL-1 cardiomyocytes (n = 13). Both CTs and CDCs represent 3 biological replicates. The heatmap illustrates expression as −∆CT values (blue indicates low or absent expression; red indicates high expression). Samples were ordered based on cell type, and the genes were grouped using a hierarchical clustering algorithm based on the underlying co-expression pattern. (B) Single-cell expression of the 43 genes tested, shown individually for the four cell populations, with the mean represented as a black diamond in each group.
Figure 2. Single-cell analysis reveals enrichment of Tcf21 and low expression of Tbx5 in CTs compared to CDCs and CFs. (A) Expression of 43 genes was analysed at the single-cell level in the four cell populations shown: CTs (n = 55), CDCs (n = 41), and CFs (n = 29) at passage 3, as well as HL-1 cardiomyocytes (n = 13). Both CTs and CDCs represent 3 biological replicates. The heatmap illustrates expression as −∆CT values (blue indicates low or absent expression; red indicates high expression). Samples were ordered based on cell type, and the genes were grouped using a hierarchical clustering algorithm based on the underlying co-expression pattern. (B) Single-cell expression of the 43 genes tested, shown individually for the four cell populations, with the mean represented as a black diamond in each group.
Cells 15 00384 g002aCells 15 00384 g002b
Figure 3. PCA of the three cardiac stromal populations and HL-1 cardiomyocytes. (A) PCA of the four cell populations shown: CTs (n = 55), CDCs (n = 41), and CFs (n = 29) at passage 3, as well as HL-1 cardiomyocytes (n = 13). Both CTs and CDCs represent 3 biological replicates. Dim.1 separates the cardiac stromal populations, whereas Dim.2 shows a distinct separation between cardiac stromal and myocyte populations. Gene loadings contributing to each Dim suggest that a small subset of genes explains the cross-group variability captured by Dim.1 and Dim.2. Tcf21 is associated with CTs (emphasised by the blue circle), whereas Tbx5 is associated with CDCs and CFs (emphasised by the brown circle). The separation between cardiac stromal and myocyte populations is reflected by clustering of core cardiac and cardiomyocyte genes (Nkx2-5, Wif1, Nppa, Myl2, and Myh6), which are emphasised by the pink circle. (B) PCA of the three cardiac stromal populations alone: CTs (n = 28), CDCs (n = 41), and CFs (n = 27). Both CTs and CDCs represent 3 biological replicates. Gene loadings contributing to each Dim show that Tcf21 is associated with CTs, whereas Tbx5 is associated with CDCs and CFs.
Figure 3. PCA of the three cardiac stromal populations and HL-1 cardiomyocytes. (A) PCA of the four cell populations shown: CTs (n = 55), CDCs (n = 41), and CFs (n = 29) at passage 3, as well as HL-1 cardiomyocytes (n = 13). Both CTs and CDCs represent 3 biological replicates. Dim.1 separates the cardiac stromal populations, whereas Dim.2 shows a distinct separation between cardiac stromal and myocyte populations. Gene loadings contributing to each Dim suggest that a small subset of genes explains the cross-group variability captured by Dim.1 and Dim.2. Tcf21 is associated with CTs (emphasised by the blue circle), whereas Tbx5 is associated with CDCs and CFs (emphasised by the brown circle). The separation between cardiac stromal and myocyte populations is reflected by clustering of core cardiac and cardiomyocyte genes (Nkx2-5, Wif1, Nppa, Myl2, and Myh6), which are emphasised by the pink circle. (B) PCA of the three cardiac stromal populations alone: CTs (n = 28), CDCs (n = 41), and CFs (n = 27). Both CTs and CDCs represent 3 biological replicates. Gene loadings contributing to each Dim show that Tcf21 is associated with CTs, whereas Tbx5 is associated with CDCs and CFs.
Cells 15 00384 g003
Figure 4. Statistical analysis of the single-cell qRT-PCR and gene correlations. (A) Statistical analysis using the Kruskal–Wallis test followed by Dunn’s post hoc test on the four cell populations shown: CTs (n = 55), CDCs (n = 41), and CFs (n = 29) at passage 3, as well as HL-1 cardiomyocytes (n = 13). Both CTs and CDCs represent 3 biological replicates. The heatmap illustrates p-values from 0 to 0.1 (orange to blue, low to high). The red bar indicates that the Kruskal–Wallis/Dunn test was applied across all samples. The genes were grouped using a hierarchical clustering algorithm based on the underlying co-expression pattern. (B) Gene–gene correlation plot using the Spearman coefficient, derived from the entire single-cell qRT-PCR dataset, is represented by the colour of the dots (blue indicates negative correlation; red indicates positive correlation). Both the diameter and colour intensity of each dot are proportional to the level of correlation.
Figure 4. Statistical analysis of the single-cell qRT-PCR and gene correlations. (A) Statistical analysis using the Kruskal–Wallis test followed by Dunn’s post hoc test on the four cell populations shown: CTs (n = 55), CDCs (n = 41), and CFs (n = 29) at passage 3, as well as HL-1 cardiomyocytes (n = 13). Both CTs and CDCs represent 3 biological replicates. The heatmap illustrates p-values from 0 to 0.1 (orange to blue, low to high). The red bar indicates that the Kruskal–Wallis/Dunn test was applied across all samples. The genes were grouped using a hierarchical clustering algorithm based on the underlying co-expression pattern. (B) Gene–gene correlation plot using the Spearman coefficient, derived from the entire single-cell qRT-PCR dataset, is represented by the colour of the dots (blue indicates negative correlation; red indicates positive correlation). Both the diameter and colour intensity of each dot are proportional to the level of correlation.
Cells 15 00384 g004aCells 15 00384 g004b
Table 1. Taqman probes used for single-cell qRT-PCR.
Table 1. Taqman probes used for single-cell qRT-PCR.
GeneReferenceGeneReference
Mesp1Mm00801883_g1Nkx2-5Mm00657783_m1
Mef2cMm01340842_m1Myh11Mm00443013_m1
Mef2aMm01318990_m1Cnn1Mm00487032_m1
Hand1Mm00433931_m1αSMA (Acta2)Mm01546133_m1
Islet1 (Isl1)Mm00627860_m1VimMm01333430_m1
Tbx20Mm00451515_m1Cd44Mm01277163_m1
Gata4Mm00484689_m1PdgfrbMm00435546_m1
Hand2Mm00439247_m1Ng2Mm01283063_m1
Tbx5Mm00803518_m1Ddr2Mm00445615_m1
Ly6a (Sca1)Mm00726565_s1MedagMm00551008_m1
Wt1Mm00460570_m1Ms4a4dMm00656404_m1
Klf4Mm00516104_m1Col1a1Mm00801666_g1
Pou5f1 (Oct4)Mm03053917_g1Prg4Mm01284582_m1
NanogMm02019550_s1Wif1Mm00442355_m1
TertMm0352136_m1Colec11Mm01289834_m1
KdrMm00440111_m1Kcnj8Mm00434620_m1
Cdh5Mm00486938_m1Mrc1Mm01329362_m1
VwfMm00550376_m1Cx3cr1Mm00438354_m1
PdgfraMm01211685_m1Csf1 rMm01266652_m1
Tcf21Mm00448961_m1Kcna1Mm00439977_s1
Myl2Mm00440384_m1Plp1Mm01297210_m1
Myh6Mm00440359_m1Ptprc (Cd45)Mm01293577_m1
NppaMm01255748_g1UbcMm01201237_m1
HmbsMm01143545_m1
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alonaizan, R.; Chaves-Guerrero, P.; Samari, S.; Noseda, M.; Smart, N.; Carr, C. Transcriptomic Analysis of Adult Mouse Cardiac Stromal Cells Using Single-Cell qRT-PCR. Cells 2026, 15, 384. https://doi.org/10.3390/cells15040384

AMA Style

Alonaizan R, Chaves-Guerrero P, Samari S, Noseda M, Smart N, Carr C. Transcriptomic Analysis of Adult Mouse Cardiac Stromal Cells Using Single-Cell qRT-PCR. Cells. 2026; 15(4):384. https://doi.org/10.3390/cells15040384

Chicago/Turabian Style

Alonaizan, Rita, Patricia Chaves-Guerrero, Sara Samari, Michela Noseda, Nicola Smart, and Carolyn Carr. 2026. "Transcriptomic Analysis of Adult Mouse Cardiac Stromal Cells Using Single-Cell qRT-PCR" Cells 15, no. 4: 384. https://doi.org/10.3390/cells15040384

APA Style

Alonaizan, R., Chaves-Guerrero, P., Samari, S., Noseda, M., Smart, N., & Carr, C. (2026). Transcriptomic Analysis of Adult Mouse Cardiac Stromal Cells Using Single-Cell qRT-PCR. Cells, 15(4), 384. https://doi.org/10.3390/cells15040384

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop